FDA Backs Teva's Generic Nexium In Blow To Ranbaxy
The U.S. Food and Drug Administration on Monday approved Teva Pharmaceutical Industries Ltd.'s generic version of AstraZeneca PLC's blockbuster heartburn drug Nexium, prompting an immediate response in D.C. federal court by...To view the full article, register now.
Already a subscriber? Click here to view full article